SP0218 / Sanofi - LARVOL DELTA

Phase 3 Single Arm, Open Study on vYF in Adults (clinicaltrials.gov) - P3 | N=254 | Active, not recruiting | Sponsor: Sanofi Pasteur, a Sanofi Company | Recruiting ➔ Active, not recruiting | Trial completion date: Apr 2026 ➔ Dec 2025 | Trial primary completion date: Apr 2026 ➔ Dec 2025

Enrollment closed • Trial completion date • Trial primary completion date

Phase 3 Single Arm, Open Study on vYF in Adults (clinicaltrials.gov) - P3 | N=254 | Recruiting | Sponsor: Sanofi Pasteur, a Sanofi Company | Not yet recruiting ➔ Recruiting

Enrollment open

Phase 3 Single Arm, Open Study on vYF in Adults (clinicaltrials.gov) - P3 | N=254 | Not yet recruiting | Sponsor: Sanofi Pasteur, a Sanofi Company

New P3 trial

A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population (clinicaltrials.gov) - P3 | N=2440 | Recruiting | Sponsor: Sanofi | Trial completion date: Oct 2029 ➔ Mar 2030

Trial completion date • Pediatrics

Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults (clinicaltrials.gov) - P3 | N=640 | Active, not recruiting | Sponsor: Sanofi | Recruiting ➔ Active, not recruiting | Trial completion date: Apr 2026 ➔ Jan 2026 | Trial primary completion date: Apr 2026 ➔ Jan 2026

Enrollment closed • Trial completion date • Trial primary completion date

A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population (clinicaltrials.gov) - P3 | N=2440 | Recruiting | Sponsor: Sanofi

New P3 trial • Pediatrics

VYF02: Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA (clinicaltrials.gov) - P2 | N=568 | Active, not recruiting | Sponsor: Sanofi Pasteur, a Sanofi Company | Trial completion date: Jun 2028 ➔ Jun 2027

Trial completion date

Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults (clinicaltrials.gov) - P3 | N=640 | Recruiting | Sponsor: Sanofi

New P3 trial

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia (clinicaltrials.gov) - P2 | N=690 | Active, not recruiting | Sponsor: Sanofi Pasteur, a Sanofi Company | Trial completion date: Apr 2028 ➔ Apr 2027

Trial completion date

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia (clinicaltrials.gov) - P2 | N=690 | Active, not recruiting | Sponsor: Sanofi Pasteur, a Sanofi Company | Trial completion date: Apr 2027 ➔ Apr 2028

Trial completion date

VYF02: Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA (clinicaltrials.gov) - P2 | N=567 | Active, not recruiting | Sponsor: Sanofi Pasteur, a Sanofi Company | Trial completion date: Jan 2027 ➔ Jun 2028

Trial completion date

VYF02: Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA (clinicaltrials.gov) - P2 | N=567 | Active, not recruiting | Sponsor: Sanofi Pasteur, a Sanofi Company | Recruiting ➔ Active, not recruiting

Enrollment closed

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia (clinicaltrials.gov) - P2 | N=690 | Active, not recruiting | Sponsor: Sanofi Pasteur, a Sanofi Company | Recruiting ➔ Active, not recruiting

Enrollment closed